FT Logo (1).png
Field Trip Health Ltd. Announces Voting Results From Special Shareholder Meeting
June 27, 2022 20:21 ET | Field Trip Health, Ltd.
TORONTO, June 27, 2022 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (TSX: FTRP, FTRP.WT, Nasdaq: FTRP) ("Field Trip" or "Corporation"), a global leader in the development and delivery of psychedelic...
FT Logo (1).png
Field Trip Health Ltd. to Present at the H.C. Wainwright 1st Annual Mental Healthcare Conference on June 27, 2022
June 23, 2022 07:41 ET | Field Trip Health, Ltd.
TORONTO, June 23, 2022 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (TSX: FTRP, FTRP.WT, Nasdaq: FTRP) ("Field Trip"), a global leader in the development and delivery of psychedelic therapies,...
FT Logo (1).png
Field Trip Health Ltd. Schedules Fiscal Fourth Quarter and Full Year 2022 Results Conference Call for Thursday, June 30, 2022 at 8:30 AM ET
June 22, 2022 14:41 ET | Field Trip Health, Ltd.
TORONTO, June 22, 2022 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (TSX: FTRP, FTRP.WT, Nasdaq: FTRP) ("Field Trip"), a global leader in the development and delivery of psychedelic therapies,...
FT Logo (1).png
Field Trip Health Ltd. Announces Increased Participation in Arrangement Financing and Postponement of Shareholder Meeting Date
June 14, 2022 18:03 ET | Field Trip Health, Ltd.
TORONTO, June 14, 2022 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (TSX: FTRP, FTRP.WT, Nasdaq: FTRP) (the "Company" or "Field Trip"), a global leader in the development and delivery of psychedelic...
FT Logo (1).png
Field Trip and Nue Life Are Collaborating To Bring Psychedelic Therapy Into the Home
May 12, 2022 07:30 ET | Field Trip Health, Ltd.
TORONTO, May 12, 2022 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (NASDAQ: FTRP, TSX: FTRP) ("Field Trip"), a leader in the development and delivery of psychedelic-assisted psychotherapy with 12...
FT Logo (1).png
Field Trip Health Ltd. to Participate in Upcoming Investor Conferences in May 2022
April 29, 2022 08:12 ET | Field Trip Health, Ltd.
TORONTO, April 29, 2022 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (TSX: FTRP, FTRP.WT, Nasdaq: FTRP) ("Field Trip"), a global leader in the development and delivery of psychedelic therapies,...
FT Logo (1).png
Field Trip Health Ltd. Announces Intention to Separate the Field Trip Discovery and Field Trip Health Divisions Into Two Independent Public Companies
April 28, 2022 18:19 ET | Field Trip Health, Ltd.
Transaction will create two distinct emerging leaders in the psychedelics industry, one providing personalized care and the other developing next generation psychedelic therapies. Shareholders of...
FT Logo (1).png
Field Trip Health Ltd. to Participate in Upcoming Investor Conferences
April 18, 2022 09:00 ET | Field Trip Health, Ltd.
TORONTO, April 18, 2022 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (TSX: FTRP, FTRP.WT, Nasdaq: FTRP) ("Field Trip"), a global leader in the development and delivery of psychedelic therapies,...
FT Logo (1).png
Field Trip Health Ltd. Granted US Patent Covering Novel Psychedelic Molecule FT-104
April 05, 2022 07:51 ET | Field Trip Health, Ltd.
TORONTO, April 05, 2022 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (NASDAQ: FTRP, TSX: FTRP) ("Field Trip"), a global leader in the development and delivery of psychedelic therapies, today announced...
FT Logo (1).png
Field Trip Health Ltd. to Participate in Maxim Group 2nd Annual Virtual Growth Conference
March 23, 2022 08:00 ET | Field Trip Health, Ltd.
TORONTO, March 23, 2022 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (TSX: FTRP, FTRP.WT, Nasdaq: FTRP) ("Field Trip"), a global leader in the development and delivery of psychedelic therapies,...